Detalhe da pesquisa
1.
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
J Transl Med
; 20(1): 225, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568909
2.
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lancet Oncol
; 22(7): 946-958, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143969
3.
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
J Transl Med
; 20(1): 317, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841045
4.
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Eur Urol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777648